The 2 most recent market catalysts affecting $TRLV, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 92
Trulieve Cannabis Q2 Adj. EPS $0.11 Beats $0.06 Estimate, Sales $271.000M Beat $268.494M Estimate
Trulieve Cannabis (TRLV) announced Q2 adjusted EPS of $0.11, which was an 83.33% beat over the analyst consensus of $0.06, and a substantial 375% increase from a loss in the prior …
Jul 20, 2026
Corporate Catalyst
Neutral
Impact 65
Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15
Cantor Fitzgerald's initiation of coverage on Trulieve Cannabis with an 'Overweight' rating and a $15 price target is a positive development for the company. Analyst coverage, espe…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.